Introduction: We aimed to investigate patient and disease variables associated with gynecological organ invasion in females with bladder cancer at the time of robot-assisted radical cystectomy (RARC). Methods: We conducted a retrospective review of female patients who underwent robot-assisted anterior pelvic exenteration (RAAE) between 2005 and 2016. Patients were divided into two groups: those with gynecological organ involvement at RAAE and those without. Data were reviewed for perioperative and pathological outcomes. Kaplan-Meier method was used to depict survival outcomes. Multivariable stepwise regression analysis was performed to identify predictors of gynecological organ involvement. Results: A total of 118 female patients were identified; 17 (14%) showed evidence of gynecological organ invasion at RAAE. Patients with gynecological organ invasion had more lymphovascular invasion at transurethral resection of bladder tumour (TURBT) (82% vs. 46%; p=0.006), trigonal tumours at TURBT (59% vs. 18%; p=0.001), multifocal disease (65% vs. 33%; p=0.01), pN+ (71% vs. 22%; p<0.001), positive surgical margins (24% vs. 4%; p=0.02), and they less commonly demonstrated pure urothelial carcinoma at TURBT (18% vs. 66%; p<0.001). On multivariate analysis, significant predictors of gynecological organ invasion were pN positive disease (odds ratio [OR] 6.48; 95% confidence interval [CI] 1.64-25.51; p=0.008), trigonal tumour location (OR 5.72; p=0.02), and presence of variant histology (OR18.52; 95% CI 3.32-103.4; p=0.001).
Introduction
The gold standard for treatment of females with muscle invasive bladder cancer (MIBC) and refractory non-muscle invasive disease is anterior pelvic exenteration [1] . Robot-assisted radical cystectomy (RARC) has been increasingly utilized, as it provides equivalent oncologic outcomes to the conventional open approach, and provides superior perioperative outcomes in terms of less blood loss, transfusion rates and improved convalescence [2] . Robot-assisted anterior pelvic exenteration (RAAE) has been shown feasible and reproducible [3] .
Recently, there has been growing interest in sparing the gynecologic pelvic organs at radical cystectomy (RC) to minimize adverse health-related quality of life (HRQoL) consequences, especially for younger patients. Prior studies have shown that anterior exenteration may pose a negative impact on females regardless of their age. Removing gynecologic organs can cause early menopause, increasing risk of osteoporosis and or the need for hormone replacement therapy (HRT), which may increase risk of breast cancer [4, 5] . Additionally, women may experience worse self-perceived body-image, more difficulties adapting to life, and decreased social functioning [6] . It also precludes female patients from future child bearing and adversely impacts their sexual lives.
Prior studies have investigated the prevalence of gynecologic organ involvement at the time of open RC, with an estimated incidence of 3-8% [7] [8] [9] . Despite the relatively low incidence, utilization of gynecologic organ sparing surgeries remains limited. In this context, we aimed to investigate the prevalence of tumor invasion into adjacent gynecologic organs, and identify predictors for gynecologic organs involvement at RAAE, which may improve risk stratification and allow better counselling for patients who wish for gynecologic organ sparing surgery.
Methods
We retrospectively reviewed our prospectively maintained RARC quality assurance database (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) Female patients were identified and divided into 2 groups: those with gynecologic organ involvement at RAAE and those without. Univariable associations between baseline characteristics and outcome measurements were statistically assessed using Fisher exact test for categorical and Wilcoxon Rank Sum test for continuous variables. Stepwise multivariate logistic regression models were fit to evaluate preoperative, operative, postoperative and pathologic predictors of gynecological organs invasion. All statistical analyses were performed using SAS software (version 9.3, SAS Institute Inc., Cary, NC). All tests were two-side, with statistical significance defined as p≤0.05.
Results

female patients underwent RAAE between 2005 and 2016
, of whom 17 (14%) exhibited direct tumor invasion into their gynecologic organs. Both groups were comparable in terms of preoperative and operative variables. There was no statistically significant difference between the two groups in terms of hospital or ICU stay, complications, readmissions, mortality at 30 and 90 days. Patients who had gynecologic organ invasion received adjuvant chemotherapy more frequently (41% vs 9%, p=0.002) ( Table 1) . They more frequently demonstrated positive pelvic lymph nodes (pN+) (71% vs 22%, p<0.001), LVI (82% vs 46%, p=0.006), positive surgical margins (24% vs 4%, p=0.02), variant/mixed histology tumors (83% vs 34%, p<0.001), trigonal tumor location (59% vs. 18% p=0.001) and multifocal tumors (65% vs. 33% p=0.01). Vaginal involvement was the most common site for female organ involvement (n=13, 76%) followed by the uterus (n=7, 41%) ( Table 2) .
On multivariate analysis, significant predictors of gynecologic organ invasion were pN+ (OR 6.48, 95% CI 1.64-25.51, p=0.008), trigonal tumor location on TURBT (OR 5.72, 95% CI 1.39-23.61, p=0.02), and presence of variant histology on TURBT (OR 18.52, 95% CI 3.32-103.4, p=0.001) ( Table 3) .
Discussion
The past decade has witnessed a dramatic increase in the utilization of RARC (<1 to >13 %) [12] . However, studies from the open RC literature have demonstrated the feasibility and safety of gynecologic organ preservation at RC, with paucity of studies investigating the prevalence of female organ involvement at RAAE (Table 4 ). Potential advantages of such an approach include avoidance of early menopause, especially in younger patients, which may pose an increased risk of cardiovascular disease and accelerated bone loss. While long-term HRT can combat these outcomes, it has been associated with long-term risk of breast cancer [4, 5] . For patients of childbearing age, removing the uterus and adnexa precludes them from future pregnancies; it is important to note that studies have demonstrated that pregnancy is safe after gynecologic organ sparing cystectomy [13, 14] . Such benefits are not limited to pre-menopausal women. Ali-ElDein et al suggested that by preserving the reproductive organs, there is less damage to the pelvic
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Whittum et al Gynecologic organ invasion at RARC fascia, thereby reducing the risk of pelvic floor prolapse [15] . Additionally, in patients who underwent neobladders, the risk of neobladder-vaginal fistula is significantly diminished even with only sparing the anterior vaginal wall [16] . From a quality of life standpoint, negative impacts of anterior exenteration have been studied and well documented. In a retrospective cohort of 62 patients who underwent anterior pelvic exenteration, Roos et al found that more physical, sexual and social problems were reported. Specifically, younger women in the study experienced greater difficulty adapting to daily life, and experienced worse body image, and adversely impacted their sexual lives [6] . In the same context, a more recent study found that the construction of a neovagina has been associated with better self-confidence, and allowed resumption of sexual function [17, 18] .
Despite the benefits of gynecologic organ sparing surgery, the question remains whether oncologic outcomes are in turn compromised. The largest cohort of patients who underwent uterus-, fallopian tube-, ovary-, and vagina sparing cystectomy followed by U-shaped ileal neobladder construction included 30 women, of whom nine died from bladder cancer, one patient had local recurrence, and five patients experienced disseminated disease. One-third of the patients had extravesical disease and DSS was 70% at 5 years [19] . These findings highlight the need for identification of better selection criteria for patients undergoing gynecologic organ sparing surgeries. Menon et al published a series of 3 cases that underwent robot-assisted gynecologic organ sparing RC, but they did not report their relapse rates or survival [20] . The prevalence of gynecologic organ invasion in our study is 14%, which is higher than previously reported [7, 8] . Ali-El-Dein et al attempted to identify predictors of gynecologic organ involvement at RC in a cohort of 609 women who underwent open anterior exenteration. They found that the risk of the genital organ involvement was low, with only 16 patients (3%) experiencing gynecologic organ invasion. Gynecologic organ involvement was more frequent with high grade tumors and urothelial cell type cancers [21] . In a similar study that included 54 women, only 3 (6%) patients experienced gynecologic organ involvement, however, they were unable to find any predictors of gynecologic organ involvement likely because of the small patient cohort [8] . We also observed a similar pattern of prior gynecologic organ involvement, where the vagina is the most common site involved [9] .
We found that pN positive disease, trigonal tumor location at TURBT, and presence of variant histology at TURBT were significant predictors of gynecologic organ invasion at RAAE. The adverse impact of pN positive status and the presence of variant histology on oncologic outcomes have been previously described [22] .The trigonal location may be associated with gynecologic organ invasion, given the anatomical proximity to the vagina posteriorly. Tumor location and presence of variant histology can be known preoperatively as part of clinical staging, and therefore can be used for better counselling of patients about the feasibility of genital sparing surgery.
Although the vast majority of female patients do not have gynecologic organ invasion at anterior pelvic exenteration, currently, the decision to perform a gynecologic sparing procedure
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is mainly based on patient and surgeon preferences. Surgeons usually rely on clinical staging (prior TURBT's and/or imaging studies) to determine the eligibility of patients for such procedure. Identifying factors associated with gynecologic organ involvement may help improve risk-stratification, and identify women who can safely undergo gynecologic organ sparing surgery rather than depriving all women of maintaining their gynecologic organs upon cystectomy. Higher risk women would continue to undergo radical surgery, given the adverse impact of disease stage on disease outcomes.
Despite the uniqueness of this study, several limitations exist. The retrospective study design has its recognized limitations. This is a single institution study; therefore generalization of the results may not be appropriate. In spite of the relatively small cohort of patients, to the best of our knowledge, this is the largest series of female patients with gynecologic organs invasion that has been reported after RAAE.
Conclusion
Trigonal tumor location and presence of variant histology at TURBT were significantly associated with gynecologic organ involvement in female patients at robot-assisted anterior pelvic exenteration. These results may help improve risk stratification and better identify candidates for gynecologic organ sparing cystectomy. Gynecologic organ invasion at RARC 
